| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.067 | 0.02 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |